Evidence map›Paper›PMID 38744985›Full record

ArticleScientific reports2024

Confined bioprinting and culture in inflatable bioreactor for the sterile bioproduction of tissues and organs.

Alexandre Dufour, Lucie Essayan, Céline Thomann, Emma Petiot, Isabelle Gay, Magali Barbaroux, Christophe Marquette

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexandre Dufour3d.FAB, CNRS, INSA, CPE-Lyon, UMR5246, ICBMS, Universite Claude Bernard Lyon 1, Villeurbanne, France.
Lucie Essayan3d.FAB, CNRS, INSA, CPE-Lyon, UMR5246, ICBMS, Universite Claude Bernard Lyon 1, Villeurbanne, France.
Céline Thomann3d.FAB, CNRS, INSA, CPE-Lyon, UMR5246, ICBMS, Universite Claude Bernard Lyon 1, Villeurbanne, France.
Emma Petiot3d.FAB, CNRS, INSA, CPE-Lyon, UMR5246, ICBMS, Universite Claude Bernard Lyon 1, Villeurbanne, France.
Isabelle GaySartorius Stedim FMT, Aubagne, France.
Magali BarbarouxSartorius Stedim FMT, Aubagne, France.
Christophe Marquette3d.FAB, CNRS, INSA, CPE-Lyon, UMR5246, ICBMS, Universite Claude Bernard Lyon 1, Villeurbanne, France. christophe.marquette@univ-lyon1.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The future of organ and tissue biofabrication strongly relies on 3D bioprinting technologies. However, maintaining sterility remains a critical issue regardless of the technology used. This challenge becomes even more pronounced when the volume of bioprinted objects approaches organ dimensions. Here, we introduce a novel device called the Flexible Unique Generator Unit (FUGU), which is a unique combination of flexible silicone membranes and solid components made of stainless steel. Alternatively, the solid components can also be made of 3D printed medical-grade polycarbonate. The FUGU is designed to support micro-extrusion needle insertion and removal, internal volume adjustment, and fluid management. The FUGU was assessed in various environments, ranging from custom-built basic cartesian to sophisticated 6-axis robotic arm bioprinters, demonstrating its compatibility, flexibility, and universality across different bioprinting platforms. Sterility assays conducted under various infection scenarios highlight the FUGU's ability to physically protect the internal volume against contaminations, thereby ensuring the integrity of the bioprinted constructs. The FUGU also enabled bioprinting and cultivation of a 14.5 cm

Indexed as

BioprintingBioreactorsPrinting, Three-DimensionalHumansSterilizationTissue EngineeringTissue ScaffoldsBioprintingBioreactorConfined environmentOrgans production

Identifiers

PMID38744985
PMCPMC11093974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.